Metabolomics expert Martin Giera (Head of the Metabolomics Group at the Leiden University Medical Center) tells us about some of the latest metabolomics developments. Is it possible that activity metabolomics could shape our future understanding of biology? Learn more.
Brendan Griffin (University College Cork, Ireland) discusses his work in early drug development in this interview with Bioanalysis Zone. Brendan talks about the most common challenges faced as well as key trends in the field of developability.
After an uncertain start to 2020, the organizing committee of the Workshop in Recent Issues in Bioanalysis (WRIB; 15–29 June 2020) converted the meeting that was due to take place in Phoenix (AZ, USA) to a virtual platform. In this round-up, we summarize some of our highlights from attending the virtual conference.
In this interview, Timothy Garrett (University of Florida, FL, USA) discusses the use of MS in his research, some of the key differences between imaging MS and LC–MS and gives some top tips for method development.
In a Bioanalysis perspective article, Rasa Santockyte (Bristol Myers Squibb, NJ, USA) explored the topic of critical reagents in LBAs and hybrid LC–MS assays. We caught up with Rasa to find out the latest in the field.
With a wealth of on demand presentations, live recordings, short courses and poster sessions made accessible in offices and homes across the world, ASMS 2020 Reboot was a pleasure to attend. We summarize some of our highlights from the virtual conference.
In this perspective article from Bioanalysis, the authors discuss the similarities and differences of critical reagents in LBAs and hybrid LC–MS assays. The authors propose that the benefits of well-characterized hybrid LC–MS assay reagents are frequently underestimated.